Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announces the publication of a landmark study validating the utility of its MyPhenome™ genetic obesity test. Published in Cell Metabolism, the peer-reviewed study is the first published research validating the clinical utility of MyPhenome’s genetic risk score to help predict weight loss response to two commonly prescribed anti-obesity medication classes: GLP-1 receptor agonists and phentermine/topiramate.
Led by Andres Acosta, MD, PhD, and his research team at Mayo Clinic, the study, „Genetic and Physiological Insights into Satiation Variability Predict Responses to Obesity Treatment,“ revealed MyPhenome test results can help reduce variability in response to obesity medications and enable clinicians to select more effective treatments based on a patient’s unique biology.
The study focused on an in-depth analysis of human satiation in more than 400 adults with obesity (BMI ?30). The study analyzed both genetic and non-genetic factors that influenced variability in the calories needed to reach fullness, or satiation („CTS“ or Calories to Satiation) and included a retrospective analysis of Phenomix’s machine learning gene risk score for CTS („ML-CTSGRS“). The ML-CTSGRS powers the insights generated by the MyPhenome test. The study demonstrated the clinical relevance of the CTSGRS by showing that individuals with a high CTS-GRS, or Hungry Brain phenotype, experience significantly greater weight loss when treated with phentermine/topiramate (phen-top), compared to those with a low CTS-GRS, or Hungry Gut phenotype.
Manage Consent
Functional Immer aktiv
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.